JNBA Financial Advisors’s GSK GSK Stock Holding History

JNBA Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.1K	Hold	745	–	–	﹤0.01%	356
2026 Q1	$41.1K	Sell	745 -177	-19%	-$9.59K	﹤0.01%	334
2025 Q4	$45.2K	Buy	922 +137	+17%	+$6.39K	﹤0.01%	321
2025 Q3	$33.9K	Hold	785	–	–	﹤0.01%	352
2025 Q2	$30.1K	Hold	785	–	–	﹤0.01%	348
2025 Q1	$30.4K	Sell	785 -160	-17%	-$5.86K	﹤0.01%	336
2024 Q4	$32K	Hold	945	–	–	﹤0.01%	333
2024 Q3	$38.6K	Hold	945	–	–	﹤0.01%	312
2024 Q2	$36.4K	Hold	945	–	–	﹤0.01%	319
2024 Q1	$40.5K	Hold	945	–	–	﹤0.01%	316
2023 Q4	$35K	Hold	945	–	–	﹤0.01%	322
2023 Q3	$34.3K	Hold	945	–	–	﹤0.01%	323
2023 Q2	$33.7K	Hold	945	–	–	﹤0.01%	331
2023 Q1	$33.6K	Sell	945 -45	-5%	-$1.57K	﹤0.01%	328
2022 Q4	$34.8K	Hold	990	–	–	﹤0.01%	314
2022 Q3	$29K	Sell	990 -1	-0.1%	-$38	﹤0.01%	334
2022 Q2	$54K	Buy	991 +45	+5%	+$2.48K	0.01%	271
2022 Q1	$52K	Sell	946 -69	-7%	-$3.75K	0.01%	284
2021 Q4	$56K	Buy	1,015 +346	+52%	+$18K	0.01%	291
2021 Q3	$32K	Buy	669 +342	+105%	+$17.2K	﹤0.01%	344
2021 Q2	$16K	Hold	327	–	–	﹤0.01%	428
2021 Q1	$15K	Hold	327	–	–	﹤0.01%	420
2020 Q4	$15K	Hold	327	–	–	﹤0.01%	394
2020 Q3	$15K	Hold	327	–	–	﹤0.01%	372
2020 Q2	$17K	Hold	327	–	–	﹤0.01%	352
2020 Q1	$16K	Hold	327	–	–	﹤0.01%	333
2019 Q4	$19K	Buy	327 +229	+234%	+$12.7K	﹤0.01%	354
2019 Q3	$5K	Hold	98	–	–	﹤0.01%	473
2019 Q2	$5K	Hold	98	–	–	﹤0.01%	508
2019 Q1	$5K	Sell	98 -138	-58%	-$6.9K	﹤0.01%	450
2018 Q4	$11K	Buy	236 +136	+136%	+$6.7K	﹤0.01%	371
2018 Q3	$5K	Sell	100 -162	-62%	-$8.23K	﹤0.01%	424
2018 Q2	$13K	Buy	262 +3	+1%	+$151	﹤0.01%	373
2018 Q1	$13K	Buy	259 +161	+164%	+$7.5K	﹤0.01%	351
2017 Q4	$4K	Hold	98	–	–	﹤0.01%	418
2017 Q3	$5K	Hold	98	–	–	﹤0.01%	399
2017 Q2	$5K	Hold	98	–	–	﹤0.01%	386
2017 Q1	$5K	Hold	98	–	–	﹤0.01%	398
2016 Q4	$5K	Sell	98 -4,678	-98%	-$231K	﹤0.01%	408
2016 Q3	$257K	Buy	4,776 +4,585	+2,401%	+$251K	0.04%	188
2016 Q2	$10K	Hold	191	–	–	﹤0.01%	345
2016 Q1	$10K	Hold	191	–	–	﹤0.01%	352
2015 Q4	$10K	Buy	191 +93	+95%	+$4.74K	﹤0.01%	346
2015 Q3	$5K	Hold	98	–	–	﹤0.01%	405
2015 Q2	$5K	Hold	98	–	–	﹤0.01%	409
2015 Q1	$6K	Hold	98	–	–	﹤0.01%	401
2014 Q4	$5K	Hold	98	–	–	﹤0.01%	417
2014 Q3	$6K	Hold	98	–	–	﹤0.01%	423
2014 Q2	$7K	Hold	98	–	–	﹤0.01%	385
2014 Q1	$7K	Hold	98	–	–	﹤0.01%	364
2013 Q4	$7K	Hold	98	–	–	﹤0.01%	339
2013 Q3	$6K	Hold	98	–	–	﹤0.01%	342
2013 Q2	$6K	Buy	+98	New	+$6.22K	﹤0.01%	295

Other funds holding GSK

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

KFP

Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $136M AUM

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

JNBA Financial Advisors's GSK Position: Q2 2026 in Review

JNBA Financial Advisors held its GSK (GSK) position steady in Q2 2026 at 745 shares worth $39.1K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

JNBA Financial Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $257K in Q3 2016. 332 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

JNBA Financial Advisors held 745 shares of GSK worth $39.1K as of Q2 2026.
JNBA Financial Advisors left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #356 holding.
JNBA Financial Advisors first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
JNBA Financial Advisors's GSK position peaked at $257K in Q3 2016.
332 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.